Ashland Inc. (NYSE: ASH) today announced it has appointed William G. Dempsey, a long-time pharmaceutical industry executive, to its board of directors.
Dempsey previously served in various executive positions with Abbott Laboratories from 1982-2007, including executive vice president of global pharmaceuticals from 2006, senior vice president of pharmaceutical operations from 2003 and senior vice president of international operations from 1999. He currently serves as a director of Landauer Inc. (NYSE: LDR) and Hill-Rom Holdings (NYSE: HRC). He also served on the board of Hospira, Inc. through September 2015 and Nordion, Inc. through 2014. Dempsey has previously served as chairman of the International Section of the Pharmaceutical Research and Manufacturers of America(PhRMA) and as chairman of the Accelerating Access Initiative, a cooperative public-private partnership of UNAIDS, the World Bank and six research-based pharmaceutical companies. He also previously served as member of the Salvation Army Advisory Board in Chicago. Dempsey continues to serve on the board of trustees for the Guadalupe Center in Immokalee, Florida.
“Bill’s significant experience within the pharmaceutical industry – a core growth market for Ashland – as well as within international operations makes him an ideal addition to the Ashland board,” said William A. Wulfsohn, Ashland chairman and chief executive officer. “We believe his strategic insights and industry perspective will prove valuable as we position Ashland to be the world’s premier specialty chemicals company.”
